News
GlobalData on MSN8h
Sanofi to acquire Vicebio’s share capital for $1.15bn upfrontSanofi has signed an agreement to acquire UK-based biotechnology company Vicebio’s share capital for $1.15bn upfront, to expand its vaccine development capabilities. The deal also includes additional ...
Respiratory syncytial virus (RSV) is a well-known cause of infections in children, but it's understudied in older individuals. In a retrospective study published in the Journal of the American ...
News Medical on MSN4h
RSV causes severe outcomes and heart complications in older adultsRespiratory syncytial virus (RSV) is a well-known cause of infections in children, but it's understudied in older individuals ...
Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback